SKU:BT-MCA0843
LEDGF Monoclonal Antibody
LEDGF Monoclonal Antibody
A chromosomal aberration involving PSIP1 is associated with pediatric acute myeloid leukemia (AML) with intermediate characteristics between M2-M3 French-American-British (FAB) subtypes. Translocation t(9;11)(p22;p15) with NUP98. The chimeric transcript is an in-frame fusion of NUP98 exon 8 to PSIP1/LEDGF exon 4.,domain:Residues 340-417 are necessary and sufficient for the interaction with HIV-1 IN (IBD domain).,function:Transcriptional coactivator involved in neuroepithelial stem cell differentiation and neurogenesis. Involved in particular in lens epithelial cell gene regulation and stress responses. May play an important role in lens epithelial to fiber cell terminal differentiation. May play a protective role during stress-induced apoptosis. Isoform 2 is a more general and stronger transcriptional coactivator.
Introducing the LEDGF Monoclonal Antibody, a cutting-edge biotechnological solution designed to revolutionize the field of molecular research. This highly specialized antibody is meticulously crafted to target and bind with the Lens Epithelium-Derived Growth Factor (LEDGF), a crucial protein involved in various cellular processes.
The LEDGF Monoclonal Antibody boasts exceptional specificity and affinity, ensuring precise and reliable detection of LEDGF in a wide range of biological samples. Its advanced formulation guarantees minimal cross-reactivity, thereby minimizing false positives and maximizing experimental accuracy.
With its superior performance, the LEDGF Monoclonal Antibody enables researchers to delve deeper into the intricate mechanisms governed by LEDGF. By facilitating the identification and characterization of LEDGF-associated pathways, this antibody empowers scientists to unravel the complexities of gene regulation, DNA repair, and chromatin organization.
Furthermore, the LEDGF Monoclonal Antibody exhibits exceptional versatility, making it an invaluable tool across various research disciplines. Whether investigating the role of LEDGF in cancer biology, viral integration, or neurodegenerative disorders, this antibody provides unparalleled insights into the underlying molecular processes.
Manufactured under stringent quality control measures, the LEDGF Monoclonal Antibody guarantees reproducibility and consistency, ensuring reliable results across experiments. Its robust design and long shelf life make it an ideal choice for laboratories seeking a dependable and durable reagent.
In summary, the LEDGF Monoclonal Antibody represents a breakthrough in molecular research, offering researchers an indispensable tool to unravel the intricate workings of LEDGF-associated pathways. With its exceptional specificity, versatility, and reliability, this antibody is poised to drive scientific advancements and pave the way for groundbreaking discoveries in the field.